Cytoplasmic chromatin fragments—from mechanisms to therapeutic potential

  1. Karl N Miller  Is a corresponding author
  2. Nirmalya Dasgupta
  3. Tianhui Liu
  4. Peter D Adams
  5. Maria Grazia Vizioli  Is a corresponding author
  1. Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, United States
  2. Cancer Research United Kingdom Beatson Institute, Garscube Estate, United Kingdom
  3. Institute of Cancer Sciences, University of Glasgow, Garscube Estate, United Kingdom
  4. Department of Physiology and Biomedical Engineering, Mayo Clinic, United States
  5. Robert and Arlene Kogod Center on Aging, Mayo Clinic, United States

Peer review process

This article was accepted for publication as part of eLife's original publishing model.

History

  1. Version of Record published
  2. Accepted
  3. Received

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Karl N Miller
  2. Nirmalya Dasgupta
  3. Tianhui Liu
  4. Peter D Adams
  5. Maria Grazia Vizioli
(2021)
Cytoplasmic chromatin fragments—from mechanisms to therapeutic potential
eLife 10:e63728.
https://doi.org/10.7554/eLife.63728

Share this article

https://doi.org/10.7554/eLife.63728